SCHEMBL24060484

SCHEMBL24060484

CC(C)(C)[Si](C)(C)OC1C[C@H](n2cnc3c(=O)[nH]c4nccn4c32)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(N)ncnc32)O[C@@H]1COP(=O)(O)O

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ RNASEL Q05823 3/20 0.45
▸ DTYMK P23919 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22340091 0.90 POLB (0.55) RNASELDTYMK
SCHEMBL22340317 0.90 RNASEL (0.47) RNASELDTYMK
SCHEMBL22340089 0.89 RNASEL (0.46) RNASELDTYMK
SCHEMBL22340271 0.86 POLB (0.53) DTYMK
SCHEMBL22340220 0.84 DTYMK (0.44) RNASELDTYMK
SCHEMBL22340261 0.81 POLB (0.54) DTYMK
SCHEMBL22340083 0.81 POLB (0.45) DTYMK
SCHEMBL24060675 0.81 DTYMK (0.52) RNASELDTYMK
SCHEMBL22340090 0.80 POLB (0.44) DTYMK
SCHEMBL22340326 0.79 POLB (0.42) DTYMK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3676279-B1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL MYERS SQUIBB CO (US) 2021-12-01 — — EP disclosed
Send feedback